Thermo Fisher Scientific Launches New External Molecular Control Panel for the Analytical Evaluation of BCR-ABL Test Methods Read more
Horizon Therapeutics plc Initiates PROTECT Trial Evaluating KRYSTEXXA (pegloticase injection) Read more
Trastuzumab deruxtecan granted FDA Priority Review for treatment of patients with HER2-positive metastatic breast cancer Read more
ArsenalBio Launches With $85 Million Series A Financing to Advance New Paradigm to Discover and Develop Immune Cell Therapies Read more
ViiV Healthcare Submits Supplemental New Drug Application to US FDA for Use of Dovato in Virologically Suppressed Adults with HIV-1 Read more
Mesoblast and Lonza Enter into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Therapy Read more
HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Galapagos NV Read more